Interleukin-2, interferon-alpha and interleukin-2 plus interferon-alpha in renal cell carcinoma. A randomized phase II trial.
Boccardo F, Rubagotti A, Canobbio L, Galligioni E, Sorio R, Lucenti A, Cognetti F, Ruggeri E, Landonio G, Baiocchi C, Besana C, Citterio G, De Rosa M, Calabresi F.
Boccardo F, et al. Among authors: canobbio l.
Tumori. 1998 Sep-Oct;84(5):534-9. doi: 10.1177/030089169808400505.
Tumori. 1998.
PMID: 9862512
Clinical Trial.